MDT

95.97

-0.18%↓

A

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

A

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

A

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

A

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

A

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

Search

Catalyst Pharmaceuticals Inc

Cerrado

SectorSalud

23.12 -0.86

Resumen

Variación precio

24h

Actual

Mínimo

23

Máximo

23.18

Métricas clave

By Trading Economics

Ingresos

675K

53M

Ventas

1.8M

148M

P/B

Media del Sector

14.07

88.032

Margen de beneficio

35.57

Empleados

181

EBITDA

1.7M

80M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+46.87% upside

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

333M

3B

Apertura anterior

23.98

Cierre anterior

23.12

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

142 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bearish Evidence

Catalyst Pharmaceuticals Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

2 ene 2026, 22:45 UTC

Principales Movimientos del Mercado

GH Research Shares Up, Plans to Provide Update on New Drug Application

4 ene 2026, 23:50 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Gold Rises Amid Geopolitical Risks After Maduro's Ouster -- Market Talk

4 ene 2026, 23:50 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Nikkei May Decline After Removal of Venezuela's Maduro -- Market Talk

4 ene 2026, 23:41 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Global Forex and Fixed Income Roundup: Market Talk

4 ene 2026, 23:40 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Markets Mostly Calm as Venezuelan Raid Weighed -- Market Talk

4 ene 2026, 23:35 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Oil Declines on Oversupply Worries After Maduro's Ouster -- Market Talk

4 ene 2026, 23:19 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Global Energy Roundup: Market Talk

4 ene 2026, 23:19 UTC

Charlas de Mercado
Noticias de Eventos Importantes

ONGC Could Receive $500M in Unpaid Dividends From U.S. Takeover of Venezuelan Oil -- Market Talk

4 ene 2026, 23:17 UTC

Noticias de Eventos Importantes

Spot Gold Rises 0.8% to $4,365.24/oz

4 ene 2026, 23:16 UTC

Noticias de Eventos Importantes

Spot Gold Rises After U.S.' Removal of Venezuela's Maduro

4 ene 2026, 23:14 UTC

Noticias de Eventos Importantes

Front-Month WTI Crude Oil Futures Fall 0.6%; Front-Month Brent Crude Oil Futures Drop 0.5%

4 ene 2026, 23:13 UTC

Noticias de Eventos Importantes

Front-Month Crude Oil Futures Fall After Ouster of Venezuela's Maduro

4 ene 2026, 23:12 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Reliance Industries' Could Benefit from U.S. Takeover of Venezuelan Oil -- Market Talk

4 ene 2026, 22:37 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Gold Can Gain From Flight to Quality, Central Bank Demand After Maduro Ouster -- Market Talk

4 ene 2026, 21:00 UTC

Ganancias

An On-Time Jobs Report. Plus, Albertsons, Constellation, Jefferies, and More Stocks to Watch this Week. -- Barrons.com

4 ene 2026, 20:49 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Global Energy Roundup: Market Talk

4 ene 2026, 20:49 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Jitters About Potential for U.S. Actions Elsewhere Could Grow -- Market Talk

3 ene 2026, 18:59 UTC

Noticias de Eventos Importantes

Update: Trump Says U.S. Will 'Run' Venezuela After Maduro Is Flown to New York -- Barrons.com

3 ene 2026, 17:42 UTC

Noticias de Eventos Importantes

The Oil Sector's Biggest Winners and Losers From Venezuela Regime Change -- Barrons.com

3 ene 2026, 17:40 UTC

Noticias de Eventos Importantes

Trump Says U.S. Will 'Run' Venezuela After Maduro Is Flown to New York -- Barrons.com

3 ene 2026, 16:10 UTC

Noticias de Eventos Importantes

What Maduro's Capture Means for Chevron Stock -- Barrons.com

3 ene 2026, 15:53 UTC

Noticias de Eventos Importantes

Update: Venezuela's Maduro Captured by U.S. and Flown Out of Country, Trump Says -- Barrons.com

3 ene 2026, 15:03 UTC

Noticias de Eventos Importantes

Update: Venezuela's Maduro Captured by U.S. and Flown Out of Country, Trump Says -- Barrons.com

3 ene 2026, 14:10 UTC

Noticias de Eventos Importantes

Update: Venezuela's Maduro Captured by U.S. and Flown Out of Country, Trump Says -- Barrons.com

3 ene 2026, 12:16 UTC

Noticias de Eventos Importantes

U.S. Captures Maduro, Trump Says -- Barrons.com

3 ene 2026, 09:20 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Tech, Media & Telecom Roundup: Market Talk

3 ene 2026, 09:20 UTC

Charlas de Mercado
Ganancias

Auto & Transport Roundup: Market Talk

3 ene 2026, 00:43 UTC

Adquisiciones, fusiones, absorciones

Research Reports -- Barrons.com

2 ene 2026, 22:13 UTC

Charlas de Mercado
Ganancias

Tesla Seen As Quiet on Artificial-Intelligence Efforts -- Market Talk

2 ene 2026, 21:50 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Tech, Media & Telecom Roundup: Market Talk

Comparación entre iguales

Cambio de precio

Catalyst Pharmaceuticals Inc Esperado

Precio Objetivo

By TipRanks

46.87% repunte

Estimación a 12 meses

Media 34 USD  46.87%

Máximo 35 USD

Mínimo 33 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Catalyst Pharmaceuticals Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

5 ratings

5

Comprar

0

Mantener

0

Vender

Puntuación técnica

By Trading Central

N/A / 24.28Soporte y Resistencia

Corto Plazo

Bearish Evidence

Medio plazo

Bullish Evidence

Largo Plazo

Bullish Evidence

Sentimiento

By Acuity

142 / 374 Clasificación en Salud

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Catalyst Pharmaceuticals Inc

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was founded in 2002 and is based in Coral Gables, Florida.
help-icon Live chat